Justin Tomal is a Gastroenterology physician. OpenAlex indexes 12 publications with 367 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1200 Garrity Blvd
Nampa, ID 836873402
Telephone
208-343-6458Provider last certified this registry record 6 Aug 2020.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Enterra Medical, Inc.Program year20251 payment
- ABBVIE INC.Program year20252 payments
- Braintree Laboratories, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86.5%Serotonin-3 Receptor Antagonist41.4%Ondansetron Odt100%Part D≥335 patientsProton pump inhibitor27.1%Omeprazole55%Pantoprazole Sodium36%Esomeprazole Magnesium9%Part D<11 patients+ 5 more classes in this area
Cardiovascular
6.4%Loop diuretic3.1%Furosemide100%Part D<11 patientsAldosterone antagonist (MRA)1.9%Spironolactone100%Part D<11 patients+ 1 more class in this area
Respiratory
5.2%Corticosteroid3.8%Budesonide Dr61%Budesonide Ec39%Part D<11 patientsPhenothiazine1.4%Promethazine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- S0518 Next-Day Screening Colonoscopy Following Inadequate Bowel Preparation May Improve Quality of Preparation and Adenoma Detection in a Veteran Population
The American Journal of Gastroenterology
2020 - Celiac patients' attitudes regarding novel therapies.
PubMed
2016 - U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis
Inflammatory Bowel Diseases
2015 - P-033 YI Patients With Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis
Inflammatory Bowel Diseases
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”